Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study)

BACKGROUND: The Y-AIDA study was designed to investigate the renal- and home blood pressure (BP)-modulating effects of add-on dapagliflozin treatment in Japanese individuals with type 2 diabetes mellitus (T2DM) and albuminuria. METHODS: We conducted a prospective, multicenter, single-arm study. Eigh...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinguchi, Sho, Wakui, Hiromichi, Ito, Yuzuru, Kondo, Yoshinobu, Azushima, Kengo, Osada, Uru, Yamakawa, Tadashi, Iwamoto, Tamio, Yutoh, Jun, Misumi, Toshihiro, Aoki, Kazutaka, Yasuda, Gen, Yoshii, Taishi, Yamada, Takayuki, Ono, Syuji, Shibasaki-Kurita, Tomoko, Hosokawa, Saho, Orime, Kazuki, Hanaoka, Masaaki, Sasaki, Hiroto, Inazumi, Kohji, Yamada, Taku, Kobayashi, Ryu, Ohki, Kohji, Haruhara, Kotaro, Kobayashi, Yusuke, Yamanaka, Takeharu, Terauchi, Yasuo, Tamura, Kouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710883/
https://www.ncbi.nlm.nih.gov/pubmed/31455298
http://dx.doi.org/10.1186/s12933-019-0912-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710883/
https://www.ncbi.nlm.nih.gov/pubmed/31455298
http://dx.doi.org/10.1186/s12933-019-0912-3

Ejemplares similares